Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The COVID-19 pandemic has caused an increase in the need for blood bags. People with weakened immune systems have acquired COVID-19, requiring hospitalization and blood transfusions. The pandemic thus had a favorable impact on the demand for blood bags and other medical equipment.
The expansion of the Australia Blood Bags market would also be impacted by rising fatal accident rates in the upcoming years. However, the overuse of blood bags is producing hazardous waste, which may restrain the market for blood bags in Australia from expanding in the upcoming years.
Increasing Incidences of Blood-Related Disorders
Australia, like many other countries around the world, has been experiencing an increase in the incidence of blood-related disorders. These disorders can range from anemia to more serious conditions such as leukemia or thalassemia. As the number of people diagnosed with these conditions increases, so does the demand for blood bags.More than 275,000 Australians are anticipated to have blood cancer or blood disease by 2035. In Australia, it's anticipated that more than 5,950 individuals will die prematurely from blood cancer or other related blood illnesses in 2023. This translates to 16 people each day. The rise in blood-related ailments in Australia is expected to fuel the demand for blood bags there in the years to come.
Rise in Number of Road Accidents
Road accidents in Australia are a result of factors such as exceeding the speed limit, drunk driving, driver fatigue, driver distraction, etc. There are around 1,123 deaths in 2021. This represents a 2.6% increase from 2020. The population's growing awareness of blood donation is driving the market's growth. Moreover, the expansion of government and non-profit organizations' investments in healthcare infrastructure, diagnostic facilities, and medical research labs will accelerate market growth. Road accidents result in serious injuries that, in turn lead to blood loss and urgent blood transfusions. The expansion of the Australia Blood Bags market during the forecast period is being impacted by the rising number of traffic accidents.Market Segmentation
Australia Blood Bags Market can be segmented on the basis of product type, type, volume, material, end user, and region. Based on product type, the market can be further divided into single blood bag, double blood bag, triple blood bag, quadruple blood bag, and penta blood bag. Based on type, the market is further bifurcated into collection bag v/s transfer bag. Based on volume, the market is divided into 100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, and 500ml. Based on material, the market is divided into PVC, PET, and Others. Based on end users, the market is divided into hospitals, clinics, ambulatory surgical centers, blood banks, and others.Market Players
Terumo Australia Pty Ltd., Fresenius Kabi Australia Pty Limited, Grifols Australia, Teleflex Medical Australia Pty Ltd, Haemologic Biotech, SSS Australia Healthcare Supplies, Medilogic, and Lifeblood are some of the leading players operating in the Australia Blood Bags Market.Report Scope
In this report, Australia Blood Bags Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:Australia Blood Bags Market, By Product Type:
- Single Blood Bag
- Double Blood Bag
- Triple Blood Bag
- Quadruple Blood Bag
- Penta Blood Bag
Australia Blood Bags Market, By Type:
- Collection Bag
- Transfer Bag
Australia Blood Bags Market, By Volume:
- 100ml
- 150ml
- 250ml
- 300ml
- 350ml
- 400ml
- 450ml
- 500ml
Australia Blood Bags Market, By Material:
- PVC
- PET
- Others
Australia Blood Bags Market, By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Center
- Blood Banks
- Others
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Australia Blood Bags market.Available Customizations
With the given market data, the analyst offers customizations according to a company’s specific needs. The following customization options are available for the report.Company Information
Detailed analysis and profiling of additional market players (up to five).This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Terumo Australia Pty Ltd.
- Fresenius Kabi Australia Pty Limited
- Grifols Australia
- Teleflex Medical Australia Pty Ltd.
- Haemologic Biotech
- SSS Australia Healthcare Supplies
- Medilogic
- Lifeblood